PFIZER SELF-PRESENTATION ABOUT SUSTAINABILITY AND CSR - THE MESSAGE FROM ITS 2020 REPORTS
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F26482789%3A_____%2F21%3A10152343" target="_blank" >RIV/26482789:_____/21:10152343 - isvavai.cz</a>
Result on the web
<a href="https://www.mup.cz/data/files/IFRS2021-sbornik.pdf" target="_blank" >https://www.mup.cz/data/files/IFRS2021-sbornik.pdf</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
PFIZER SELF-PRESENTATION ABOUT SUSTAINABILITY AND CSR - THE MESSAGE FROM ITS 2020 REPORTS
Original language description
Today's global society is increasingly interested in the issue of sustainability and this leads to expectations about the responsible behaviour of all stakeholders, especially those able to afford to do so. The pharmaceutical industry is among those industries expected to exhibit a strong corporate social responsibility (CSR), and multinational pharmaceutical corporations such as Pfizer have engaged in both financial and non-financial reporting. COVID-19 brought new dynamics in this setting and Pfizer was seen by a section of the public as a corporation exclusively focusing on profit maximization and denying CSR, while for others it is a prime example of an effectively and efficiently operating, pro-CSR business. Logically, the assessment of the role and function of Pfizer, above and beyond the Pfizer-BioNTech COVID-19 vaccine, vis-a-vis sustainability and CSR, begins with a critical Meta-Analysis of their most recently e-published CSR report - Environmental, Social & Governance Report 2020 (ESG Report 2020) along with the general Pfizer 2020 Annual Review. The holistic exploration of this Report, based on the 6 CSR categories, leads to pioneering revelations about the inside perception and self-presentation regarding CSR. These revelations are complemented and refreshed by Socratic questioning and glossing and culminate in conclusions casting a new light on Pfizer Inc.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
—
OECD FORD branch
50501 - Law
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
Conference Proceedings 9th International Scientific Conference IFRS: GLOBAL RULES & LOCAL USE - BEYOND THE NUMBERS
ISBN
978-80-7638-027-1
ISSN
—
e-ISSN
—
Number of pages
10
Pages from-to
60-69
Publisher name
Metropolitan University Prague, Prague & Anglo-American University, Prague
Place of publication
Praha
Event location
Praha
Event date
Oct 7, 2021
Type of event by nationality
WRD - Celosvětová akce
UT code for WoS article
—